Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Martínez, E, Arranz, JA, Podzamczer, D, Lonca, M, Sanz, J, Barragán, P, Knobel, H, Ribera, E, Gutierrez, F, Valero, S, Clotet, B, Dalmau, D, Segura, F, Arribas, JR, Barrufet, P, Santos, I, Payeras, A, de Lazzari, E, Pich, J, Gatell, J
Format: Artigo
Jezik:Inglês
Izdano: The International AIDS Society 2010
Teme:
Poster Presentation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113046/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2652-13-S4-P43
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki